138 related articles for article (PubMed ID: 36939458)
1. The Course of Hearing Loss in Patients With a Progressive Vestibular Schwannoma.
Koetsier KS; Locher H; Koot RW; van der Mey AGL; van Benthem PG; Jansen JC; Hensen EF;
Otolaryngol Head Neck Surg; 2023 Sep; 169(3):622-632. PubMed ID: 36939458
[TBL] [Abstract][Full Text] [Related]
2. Progression of Hearing Loss in Observed Non-Growing Vestibular Schwannoma.
Luryi AL; Babu S; Bojrab DI; Kveton JF; Schutt CA
Otol Neurotol; 2022 Aug; 43(7):e767-e772. PubMed ID: 35763454
[TBL] [Abstract][Full Text] [Related]
3. Hearing improvement after middle fossa resection of vestibular schwannoma.
Stidham KR; Roberson JB
Otol Neurotol; 2001 Nov; 22(6):917-21. PubMed ID: 11698819
[TBL] [Abstract][Full Text] [Related]
4. Sensorineural hearing loss after occlusion of the enlarged vestibular aqueduct.
Welling DB; Slater PW; Martyn MD; Antonelli PJ; Gantz BJ; Luxford WM; Shelton C
Am J Otol; 1999 May; 20(3):338-43. PubMed ID: 10337975
[TBL] [Abstract][Full Text] [Related]
5. Hearing Loss Progresses Faster in Patients With Growing Intracanalicular Vestibular Schwannomas.
van Linge A; Borsboom GJ; Wieringa MH; Goedegebure A
Otol Neurotol; 2016 Oct; 37(9):1442-8. PubMed ID: 27579837
[TBL] [Abstract][Full Text] [Related]
6. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
7. COX inhibitor use during definitive radiotherapy is associated with worse hearing preservation in patients with vestibular schwannoma.
Huerter BG; Johnson KC; Coutu BG; Thedinger B; Bennion NR; Zheng C; Zhang C
J Neurooncol; 2023 Oct; 165(1):139-148. PubMed ID: 37889440
[TBL] [Abstract][Full Text] [Related]
8. Change in hearing and tinnitus in conservatively managed vestibular schwannomas.
Quaranta N; Baguley DM; Moffat DA
Skull Base; 2007 Jul; 17(4):223-8. PubMed ID: 18174921
[TBL] [Abstract][Full Text] [Related]
9. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
[TBL] [Abstract][Full Text] [Related]
10. Hearing in patients with intracanalicular vestibular schwannomas.
Caye-Thomasen P; Dethloff T; Hansen S; Stangerup SE; Thomsen J
Audiol Neurootol; 2007; 12(1):1-12. PubMed ID: 17033159
[TBL] [Abstract][Full Text] [Related]
11. Calculated versus measured pure tone bone conduction 3 kHz thresholds in sudden sensorineural hearing loss.
Shilo S; Ziv-Baran T; Oron Y; Handzel O; Cavel O; Eta RA; Muhanna N; Ungar OJ
J Laryngol Otol; 2021 Sep; 135(9):820-824. PubMed ID: 34308808
[TBL] [Abstract][Full Text] [Related]
12. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.
Plotkin SR; Halpin C; McKenna MJ; Loeffler JS; Batchelor TT; Barker FG
Otol Neurotol; 2010 Sep; 31(7):1135-43. PubMed ID: 20736812
[TBL] [Abstract][Full Text] [Related]
14. Consequences to hearing during the conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
[TBL] [Abstract][Full Text] [Related]
15. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
16. Cochlear origin of early hearing loss in vestibular schwannoma.
Gouveris HT; Victor A; Mann WJ
Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
[TBL] [Abstract][Full Text] [Related]
17. Durability of Hearing Preservation Following Microsurgical Resection of Vestibular Schwannoma.
Dowling EM; Patel NS; Lohse CM; Driscoll CLW; Neff BA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2019 Dec; 40(10):1363-1372. PubMed ID: 31725593
[TBL] [Abstract][Full Text] [Related]
18. Presbycusis and Hearing Preservation in Observed Vestibular Schwannomas.
Brennan JR; Sharma R; Lindquist NR; Cass ND; Krishnapura SG; Kloosterman N; Perkins E; Bennett ML; O'Malley MR; Haynes DS; Tawfik KO
Otol Neurotol; 2023 Sep; 44(8):817-821. PubMed ID: 37442597
[TBL] [Abstract][Full Text] [Related]
19. Long-term hearing outcome after retrosigmoid removal of vestibular schwannoma.
Nakamizo A; Mori M; Inoue D; Amano T; Mizoguchi M; Yoshimoto K; Sasaki T
Neurol Med Chir (Tokyo); 2013; 53(10):688-94. PubMed ID: 24077269
[TBL] [Abstract][Full Text] [Related]
20. Rate of Initial Hearing Loss During Early Observation Predicts Time to Non-Serviceable Hearing in Patients With Conservatively Managed Sporadic Vestibular Schwannoma.
Carlson ML; Dowling EM; Lohse CM; O'Connell BP; Driscoll CLW; Haynes DS; Link MJ; Hunter JB
Otol Neurotol; 2019 Dec; 40(10):e1012-e1017. PubMed ID: 31634279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
